PANTOTHENAMIDE ANALOGUES
    1.
    发明申请

    公开(公告)号:WO2020141155A1

    公开(公告)日:2020-07-09

    申请号:PCT/EP2019/087147

    申请日:2019-12-30

    Abstract: The present invention provides compounds that have antimalarial activity. More in particular, the present invention provides novel compounds that are analogues of pantothenamides. The pantothenamide analogues of this invention have particularly low IC 50 values against the asexual blood stages and gametocytes of malaria parasites. Furthermore, the pantothenamide analogues of this invention are characterized by low hepatic metabolism. Therefore, pantothenamide analogues of the invention are particularly suitable for use in therapeutic and/or prophylactic treatment of protozoan infections in a human or animal subject in need thereof. The invention further provides pharmaceutical formulations comprising the pantothenamide analogues as well as the therapeutic and/or prophylactic uses of the pantothenamide analogues and pharmaceutical formulations comprising them.

    NEW ANTI-MALARIAL AGENT
    9.
    发明申请
    NEW ANTI-MALARIAL AGENT 审中-公开
    新的抗疟疾药物

    公开(公告)号:WO2018069420A1

    公开(公告)日:2018-04-19

    申请号:PCT/EP2017/075999

    申请日:2017-10-12

    Abstract: The present invention is related to new trioxolane derivatives in the manufacture of a medicament for preventing or treating malaria. Specifically, the present invention is related to trioxolane derivatives useful for the preparation of a pharmaceutical formulation for the inhibition of malaria parasite proliferation.

    Abstract translation: 本发明涉及新的三氧杂环戊烷衍生物在制备用于预防或治疗疟疾的药物中的用途。 具体而言,本发明涉及用于制备抑制疟疾寄生虫增殖的药物制剂的三氧杂环戊烷衍生物。

Patent Agency Ranking